Form 4 for EQH Equitable Holdings, Inc.
Accepted 2025-01-16 00:00:00 ET · period of report 2025-01-15 · accession 0001628280-25-001757 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-01-16 | 2025-01-15 | EQH | Pearson Mark | Pres, CEO, Dir | S - Sale+OE | $51.65 | -30.0K | 649.9K | -4% | -$1.55M |
| DM | 2025-01-16 | 2025-01-15 | EQH | Pearson Mark | Pres, CEO, Dir | M - OptEx | $22.38 | +20.0K | 659.9K | +3% | +$447.5K |
| DM | 2025-01-16 | 2025-01-15 | EQH | Pearson Mark | Pres, CEO, Dir | M - OptEx | $0.00 | -20.0K | 446.4K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-15 | S | D | 20,000 | $51.65 | 629,938.97 | D | — | — | (F1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2024. (F5) This transaction was executed in multiple trades at prices ranging from $51.0600 to $52.0300. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Includes Restricted Stock Units. |
| 2 | Common | Common Stock | 2025-01-15 | M | A | 8,734 | $21.34 | 648,672.97 | D | — | — | (F1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2024. (F2) Includes Restricted Stock Units. |
| 3 | Common | Common Stock | 2025-01-15 | S | D | 9,877 | $51.65 | 650,061.97 | D | — | — | (F1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2024. (F3) This transaction was executed in multiple trades at prices ranging from $51.0000 to $51.9900. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Includes Restricted Stock Units. |
| 4 | Common | Common Stock | 2025-01-15 | M | A | 11,266 | $23.18 | 659,938.97 | D | — | — | (F1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2024. (F2) Includes Restricted Stock Units. |
| 5 | Common | Common Stock | 2025-01-15 | S | D | 123 | $52.03 | 649,938.97 | D | — | — | (F1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2024. (F4) This transaction was executed in multiple trades at prices ranging from $52.0100 to $52.0400. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Includes Restricted Stock Units. |
| 6 | Derivative | Employee Stock Option (right to buy) | 2025-01-15 | M | D | 8,734 | $0.00 | 457,666 | D | $21.34 · — to 2028-03-01 | 8,734 Common Stock | (F1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2024. (F6) Grant of employee stock option under the Issuer's 2019 Omnibus Incentive Plan exempt under Rule 16b-3. The options vested in three installments beginning on March 1, 2019. |
| 7 | Derivative | Employee Stock Option (right to buy) | 2025-01-15 | M | D | 11,266 | $0.00 | 446,400 | D | $23.18 · — to 2030-02-26 | 11,266 Common Stock | (F1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2024. (F7) Grant of employee stock option under the Issuer's 2019 Omnibus Incentive Plan exempt under Rule 16b-3. The options vested in three installments beginning on February 26, 2021. |